Bara Hasanain

Bara Hasanain practices at ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware.

Bara Hasanain's NPI, 1912421900, was assigned on August 1, 2017. Bara Hasanain holds Delaware license C1-0013557.

Bara Hasanain's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy, at 4755 Ogletown Stanton Road, Newark, DE 19713. The practice phone is (302) 320-2926.

Bara Hasanain's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware. Bara Hasanain is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Bara Hasanain to 2 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bara Hasanain practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Bara Hasanain's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Bara Hasanain's licenses on file in 2 states: Delaware and Maryland.

CMS data shows 962 Medicare services from Bara Hasanain across 6 procedure codes in 2024, for 324 Medicare patients. Medicare paid $73,876 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 324 Medicare patients who saw Bara Hasanain in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bara Hasanain's median patient age at 64, with 52% women.

In 2024, Bara Hasanain wrote 475 Medicare Part D claims for 146 patients. 87% of them were for generic drugs. CMS names the drug for 139 of them, across 8 drugs with 11 or more claims each, at $784 in total drug cost. In 2023, CMS named 122 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Bara Hasanain for performance year 2024, reported as part of a group. Bara Hasanain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Bara Hasanain from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $108.